Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher C Conlin

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Clinical and Translational Radiation Oncology|May 28, 2026
Trial protocol: RadTARGET, a multicenter phase II randomized controlled trial evaluating focal radiotherapy boost with de-intensification of dose to non-suspicious prostate in patients with intermediate- or high-risk prostate cancerAnna M Dornisch, Mariluz Rojo Domingo, Roberta Vezza Alexander, et al.
Journal of Magnetic Resonance Imaging : JMRI|September 18, 2024
Discrimination Between Benign and Malignant Lesions With Restriction Spectrum Imaging MRI in an Enriched Breast Cancer Screening CohortStephane Loubrie, Jingjing Zou, Ana E Rodriguez-Soto, et al.
Magnetic Resonance in Medicine|December 14, 2021
Characterization of the diffusion signal of breast tissues using multi-exponential modelsAna E Rodríguez-Soto, Maren M Sjaastad Andreassen, Lauren K Fang, et al.
Medrxiv : the Preprint Server for Health Sciences|May 7, 2026
Androgen Deprivation Therapy (ADT) and Radiotherapy (RT) with Imaging Evaluation Longitudinally (ARIEL) trial: protocol, early results, and implications of neoadjuvant ADT for focal RT boost in prostate cancerYuze Song, Mariluz Rojo Domingo, Lily Nguyen, et al.
Physics in Medicine and Biology|April 9, 2026
The role of diffusion-weighted MRI in biological image-guided radiation therapy: a roadmapJie Deng, Sirisha Tadimalla, Tyler Seibert, et al.
Journal of Applied Clinical Medical Physics|March 19, 2026
Post hoc estimation of a quantitative restriction spectrum imaging biomarker for prostate cancer detection using conventional MRIDeondre D Do, Christopher C Conlin, Aditya Bagrodia, et al.
European Urology Open Science|January 15, 2025
Advanced Restriction Imaging and Reconstruction Technology for Prostate Magnetic Resonance Imaging (ART-Pro): A Study Protocol for a Multicenter, Multinational Trial Evaluating Biparametric Magnetic Resonance Imaging and Advanced, Quantitative Diffusion Magnetic Resonance Imaging for the Detection of Prostate CancerMadison T Baxter, Christopher C Conlin, Aditya Bagrodia, et al.
European Urology Open Science|February 16, 2026
Deep Learning Artificial Intelligence and Restriction Spectrum Imaging for Patient-level Detection of Clinically Significant Prostate Cancer on Biparametric Magnetic Resonance ImagingYuze Song, Mariluz Rojo Domingo, Christopher C Conlin, et al.
The Journal of Urology|May 16, 2025
Restriction Spectrum Imaging as a Quantitative Biomarker for Prostate Cancer With Reliable Positive Predictive ValueMariluz Rojo Domingo, Deondre D Do, Christopher C Conlin, et al.
The Journal of Urology|June 24, 2025
Reply by AuthorsMariluz Rojo Domingo, Deondre D Do, Christopher C Conlin, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Clinical and Translational Radiation Oncology|May 28, 2026
Trial protocol: RadTARGET, a multicenter phase II randomized controlled trial evaluating focal radiotherapy boost with de-intensification of dose to non-suspicious prostate in patients with intermediate- or high-risk prostate cancerAnna M Dornisch, Mariluz Rojo Domingo, Roberta Vezza Alexander, et al.
Journal of Magnetic Resonance Imaging : JMRI|September 18, 2024
Discrimination Between Benign and Malignant Lesions With Restriction Spectrum Imaging MRI in an Enriched Breast Cancer Screening CohortStephane Loubrie, Jingjing Zou, Ana E Rodriguez-Soto, et al.
Magnetic Resonance in Medicine|December 14, 2021
Characterization of the diffusion signal of breast tissues using multi-exponential modelsAna E Rodríguez-Soto, Maren M Sjaastad Andreassen, Lauren K Fang, et al.
Medrxiv : the Preprint Server for Health Sciences|May 7, 2026
Androgen Deprivation Therapy (ADT) and Radiotherapy (RT) with Imaging Evaluation Longitudinally (ARIEL) trial: protocol, early results, and implications of neoadjuvant ADT for focal RT boost in prostate cancerYuze Song, Mariluz Rojo Domingo, Lily Nguyen, et al.
Physics in Medicine and Biology|April 9, 2026
The role of diffusion-weighted MRI in biological image-guided radiation therapy: a roadmapJie Deng, Sirisha Tadimalla, Tyler Seibert, et al.
Journal of Applied Clinical Medical Physics|March 19, 2026
Post hoc estimation of a quantitative restriction spectrum imaging biomarker for prostate cancer detection using conventional MRIDeondre D Do, Christopher C Conlin, Aditya Bagrodia, et al.
European Urology Open Science|January 15, 2025
Advanced Restriction Imaging and Reconstruction Technology for Prostate Magnetic Resonance Imaging (ART-Pro): A Study Protocol for a Multicenter, Multinational Trial Evaluating Biparametric Magnetic Resonance Imaging and Advanced, Quantitative Diffusion Magnetic Resonance Imaging for the Detection of Prostate CancerMadison T Baxter, Christopher C Conlin, Aditya Bagrodia, et al.
European Urology Open Science|February 16, 2026
Deep Learning Artificial Intelligence and Restriction Spectrum Imaging for Patient-level Detection of Clinically Significant Prostate Cancer on Biparametric Magnetic Resonance ImagingYuze Song, Mariluz Rojo Domingo, Christopher C Conlin, et al.
The Journal of Urology|May 16, 2025
Restriction Spectrum Imaging as a Quantitative Biomarker for Prostate Cancer With Reliable Positive Predictive ValueMariluz Rojo Domingo, Deondre D Do, Christopher C Conlin, et al.
The Journal of Urology|June 24, 2025
Reply by AuthorsMariluz Rojo Domingo, Deondre D Do, Christopher C Conlin, et al.
Pageof 4